We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

LabCorp Licenses Technology for Early Detection of Lung Cancer from Duke University

LabCorp enters into an exclusive license agreement to commercialize Duke's new blood-based assay for early detection of lung cancer.
News

Common Molecule Notifies Immune System of Prostate Cancer

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.
News

Oncology Metrics and Cureline Announce Joint Marketing Agreement

Both companies have reached an agreement to collaborate on oncology biospecimen procurement and management.
News

Luminex Receives U.S. Food and Drug Administration Clearance for xTAG™ Respiratory Viral Panel

The Company has designed the test to simultaneously detect the most prevalent respiratory viruses.
News

Breast Cancer Cells Have to Learn to Walk Before they can Run

Early stage breast cancer that has not yet invaded the surrounding tissues may already contain highly motile cells, which brings the tumor one step closer to metastasis.
News

Pfizer to Acquire CovX to Extend Biotherapeutics Investment

Acquisition will provide biotherapeutics technology platform and complementary product candidates in oncology and diabetes.
News

Nicholas Piramal Enters into a Joint Venture with ARKRAY Inc Japan

The 49:51 joint venture aims at marketing diagnostic products, mainly self-monitoring blood glucose system in the Indian market.
News

BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology

Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
News

Cancer Cell Line Developed that is Resistant to new Cancer Therapy

Researchers found the HDAC inhibitor-resistant cell line resistant to many therapies but highly sensitive to heat shock protein 90 inhibitors, another emerging cancer treatment.
News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
Advertisement